Industrial oil recycler and refiner Hydrodec has reduced its annual loss by nearly $2 million to $13.5 million (£8.8 million).
The AIM-quoted company increased turnover 48.5 per cent to $10.4 million in 2009, described by chairman Neil Gaskell as ‘a challenging year’. Hydodec had to contend with steep oil price declines and ‘teething problems’ at its first US refining plant at Canton, Ohio.
However, in volume terms, the company increased transformer oil sales by 206 per cent to 11.8 million litres. Hydrodec clinched a ‘transformational’ strategic alliance with Kobe Steel to exploit the Japanese and East Asian markets and says it is ‘on track’ to receive approval this year from the US Environmental Protection Agency to process 'PCB-contaminated oil’.
Hydrodec shares have traded between 18.5p and 6.75p over the past year and now stand at 8.5p, up 1.5p this morning and valuing the company at £25.2 million.
The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info
Latest small-cap and growth company news
Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.
The recently published O'Neill report on antimicrobial resistance shows it to be a ticking timebomb. Resistance to antibiotics raises the prospect of 10 million deaths a year by 2050. This is a big opportunity for AIM listed Motif Bio (AIM: MTFB).
Fevertree Drinks (AIM: FEVR) has been one of the most spectacular new issues on AIM in recent years, rising 412 per cent from the float price in late 2014. Today’s trading update served to emphasise why the shares are doing so well and drove them up another 15 per cent.
Fox Marble (AIM: FOX) has raised £2 million through a placing at 10p. The funds will be mainly used to complete its long-delayed marble processing factory in Kosovo. Fox has an exciting story but unfortunately is lagging way behind its original roadmap to profitability.
XL Media (AIM: XLM) has announced the result of its strategic review. I hope no one was holding their breath, because the conclusion is to carry on as usual! The good news is that trading is said to have ‘maintained its excellent start to 2016’.
Quantum Pharma (AIM: QP.) committed the cardinal sin of overpromising and under-delivering during its first year on AIM. New products took longer to come through the regulatory process than expected, which caused downgrades and a share price collapse from a high of 172p last June to the current 58p. However results for the financial year which ended in January suggest the company is getting to grips with the problems in its Niche Pharmaceuticals division.
Elecosoft (AIM: ELCO) is a specialist software company serving architects and builders. It used to be a much larger business but sold out of its building materials businesses four years ago to focus on its software arm. The challenge now is to generate some revenue growth and move off a sales plateau which has been in place since then.